期刊文献+

联合降压治疗及护理干预对高血压左室肥厚冠状动脉钙化、动脉内皮功能的影响 被引量:4

The Influence of Combined Antihypertensive Therapy and Nursing Intervention on Left Ventricular Hypertrophy,Coronary Artery Calcification and Arterial Endothelial Function
下载PDF
导出
摘要 目的探讨联合降压治疗及护理干预(小剂量氨氯地平+复方阿米洛利或小剂量氨氯地平+替米沙坦)与适当调脂(小剂量辛伐他汀)综合干预,对原发性高血压患者动脉内皮功能、左心室重构、冠状动脉粥样硬化的影响及效果。方法入选50~79岁原发性高血压伴心血管危险因素者200例,随机分为4组:A组、B组、C组及D组,A组使用小剂量氨氯地平(2.5 mg/d)+替米沙坦(40 mg/d);B组使用小剂量氨氯地平+复方阿米洛利(半片/d1);C组在使用小剂量氨氯地平+替米沙坦基础上加小剂量辛伐他汀;D组在使用小剂量氨氯地平+复方阿米洛利基础上加小剂量辛伐他汀。A组及B组患者治疗12个月前后各检查1次超声心动图,对比分析组内治疗前后左室重量指数变化和两组间的差异。C组及D组患者在联合降压治疗(小剂量氨氯地平+复方阿米洛利或小剂量氨氯地平+替米沙坦)基础上适当调脂(小剂量辛伐他汀10 mg),测定治疗12个月前后血浆ACE活性、AngⅡ浓度、肱动脉内皮依赖性舒张功能及经64排螺旋CT冠状动脉钙化检查的冠状动脉斑块的变化。所有患者均给予精细的护理干预。结果小剂量氨氯地平+替米沙坦治疗组(A组)的左室后壁与室间隔厚度在治疗12个月后显著下降(P<0.05),而左室重量及左室重量指数下降更显著(P<0.01);肱动脉内皮依赖性舒张功能明显改善;小剂量氨氯地平+复方阿米洛利治疗组(B组)治疗12个月后的左室重量及左室重量指数下降显著(P<0.05)。小剂量氨氯地平+替米沙坦+小剂量辛伐他汀治疗组(C组)及小剂量氨氯地平+复方阿米洛利治疗组+小剂量辛伐他汀(D组)患者用小剂量辛伐他汀治疗12个月后,血清总胆固醇、LDL胆固醇、ACE活性、AngⅡ浓度、LN显著下降(P值均<0.01)。C组肱动脉内皮依赖性舒张功能明显改善。结论原发性高血压患者在小剂量氨氯地平+替米沙坦或小剂量氨氯地平+复方阿米� Objective To investigate the effect of combined antihypertensive treatment and nursing intervention(low dose amlodipine + compound amiloride or small doses of amlodipine + Telmisartan) with lipid-regulating(small-dose simvastatin) intervention in patients with essential hypertensionartery endothelial function,left ventricular remodeling,coronary atherosclerosis.Methods 200 cases which were essential hypertension with cardiovascular risk factors,from 50 to 79 years,were randomly divided into 4 groups: group A,group B,group C and group D.Group A were used small dose of amlodipine(2.5 mg/d),telmisartan(40 mg/d).The use of small doses of amlodipine combined with compound amiloride(half,d1).Group C on the basis of use of small doses of amlodipine,telmisartan plus small doses of simvastatin,and Group D in the use of small doses of amlodipine compound amiloride and small doses of simvastatin.Echocardiogram were checked in group A and group B before and after 12 months.The comparative analysis of left ventricular mass index before and after treatment were performed between the two groups.Group C and Group D: in the joint step-down therapy(small dose of amlodipine compound amiloride or small doses of amlodipine,telmisartan) on the basis of appropriate lipid-lowering simvastatin 10 mg(low dose),determination of treatment the plasma ACE activity,Ang II concentration,brachial artery endothelium-dependent vasodilation,and 64-slice spiral CT coronary plaque changes before and after 12 months.All patients are therefore correspondingly fine nursing intervention.Group C and Group D patients in the United antihypertensive therapy(small dose of amlodipine compound amiloride or small doses of amlodipine,telmisartan) on the basis of appropriate lipid(simvastatin 10 mg low dose).To Detect plasma ACE activity,Ang II concentration,brachial artery endothelium-dependent vasodilation,and 64-slice spiral CT was used to detect coronary plaque changes before and after 12 months of treatment.All pati
出处 《黑龙江医学》 2012年第5期336-341,共6页 Heilongjiang Medical Journal
关键词 高血压 脂类和降脂药 动脉内皮功能 钙质沉着症 体层摄影术 X线计算机 护理干预 Hypertension Lipids and lipid-lowering drugs Artery endothelial function Calcinosis Tomography X-ray computed Nursing intervention
  • 相关文献

参考文献10

  • 1Gossse P, Sheridan D J, Zannad F, et al. Regression oflett ventricularhypertrophy in hyp ertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg; the LIVE study [ J ]. J Hyper- tens ,2000,18 : 1465 - 75. 被引量:1
  • 2Terpstra W L, May J Y, Smit A J, et al. Long- term effects ofamlodipine and lisinopril on lett ventricular mass and diastolic function in elderly, pre- viously untreated hypertensive patients: theELVERA trial[ J]. J Hypertens,2001,19:303 - 9. 被引量:1
  • 3Dupuis J, Tardif J C, Cemacek P. Cholester- ol reduction rapidlyimproves endothelial function atter acute coronary syndromes, the RECIFL trial [ J]. Cir- culation, 1999,999 ( 32 ) :3 227 - 33. 被引量:1
  • 4Waters D D,Azar R R. Should intensive cho- lesterol lowering play arole in management ofacute cor- onary syndromes [ J ] . Am J Cardiol, 2000, 86[ Suppl I :35J -43J. 被引量:1
  • 5Agaston A S,Janowits W 1 L, Hildner F J,et al. Quantification ofcoronary artery calcium using ultra- fast computed tomography [ J ] . JAm Coil Cardiol, 1990,15 (8) :827 - 32. 被引量:1
  • 6Pearson T A, Mensah G A, Alexander R W. Markers of inflammationand cardiovascular disease, application to clinical and public health practice: a statement for heahhcare professionals from the centers- for disease control and prevention an d the Am erican Heart Association[ J ]. Circulation, 2003,107 (5) :499 -512. 被引量:1
  • 7Yamagishi s' Takeuchi M. Telmisartanisa- promisingcardiometabolicsartan due to its unique PPAR - gamma - inducing property [ J ]. Med Hypoth- eses,2005,64(3) :476- 8. 被引量:1
  • 8Kurtz T W. Pravenec M. Antidiabetic mecha-nisms of angiotensittconvertingenzyme inhibitors and angiotensin II receptor antagonists:beyond the renin - angiotensin system [ J ]. J Hypertens, 2004,22 ( 12 ) : 2 253 - 61. 被引量:1
  • 9Doggrell S A. Telmisartan -killing two birds with one stone[ J]. Expert Opin Pharmacother,2004,5 (11) :2 397 -400. 被引量:1
  • 10罗助荣,盖晓波.不稳定性心绞痛患者调脂干预对颈动脉粥样硬化及C反应蛋白的影响[J].中华心血管病杂志,2004,32(11):977-980. 被引量:40

二级参考文献3

  • 1Dupuis J,Tardif JC,Cernacek P, et al. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes.The RECIFL trial.Circulation,1999,99:3227-3233. 被引量:2
  • 2Waters DD,Azar RR. Should intensive cholesterol lowering play a role in mangement of acute coronary syndromes? Am J Cardiol, 2000,86[Suppl]:35J-43J. 被引量:1
  • 3Pearson TA,Mensah GA,Alexander RW, et al. Markers of inflammation and cardiovascular disease,application to clinical and public health practice:a statement for healthcare professionals from the centers for disease control and prevention and the American H 被引量:1

共引文献39

同被引文献51

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部